跳至主要内容
临床试验/2024-519066-49-01
2024-519066-49-01招募中4 期

Electrochemotherapy versus standard radiotherapy for the treatment of basal cell carcinoma

Region Hovedstaden1 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2024年12月16日最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
52
试验地点
1
主要终点
Effect of electhrochemotherapy versus standard radiotherapy for the treatment of basal cell carcinomas less than 3 cm.

研究概览

简要总结

To compare effect of electhrochemotherapy versus standard radiotherapy for the treatment of basal cell carcinomas less than 3 cm.

入排标准

年龄范围
18 years 至 65+ years(65+ Years, 18-64 Years)
接受健康志愿者

入选标准

  • Age above 18 years
  • Biopsy verified basal cell carcinoma under 3 cm accessible for both radiotherapy and elechtrochemoterapy
  • Subject must understand patient information
  • Signed informed consent

排除标准

  • Metastatic basal cell carcinoma
  • Previous treatment with bleomycin above 200.000 Units/m2
  • Previous severe allergic reactions to bleomycin
  • Pregnancy or breast feeding
  • Participation in other trials with trial medication

结局指标

主要结局

Effect of electhrochemotherapy versus standard radiotherapy for the treatment of basal cell carcinomas less than 3 cm.

Effect of electhrochemotherapy versus standard radiotherapy for the treatment of basal cell carcinomas less than 3 cm.

次要结局

  • Adverse events
  • Cosmesis
  • Patient satisfaction

研究者

发起方
Region Hovedstaden
申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Department of Oncology

Scientific

Region Hovedstaden

研究点 (1)

Loading locations...

相似试验